Vecna vs. Seegnal

Patients have the option to utilize contactless mobile check-in alongside self-service kiosks, allowing them to pre-register and check in via their mobile devices without any staff interaction. These kiosks are specifically designed to improve the efficacy of administrative tasks, which include hospital registration and payment processing. In addition, patients are alerted through text notifications when their healthcare provider is ready to see them, enabling them to wait comfortably in their cars or outside until their appointment. This streamlined check-in method empowers healthcare personnel to focus more on delivering high-quality patient care. Vecna’s solutions are fully compatible with major healthcare systems such as Cerner, Meditech, Allscripts, and Epic, ensuring smooth integration. Moreover, the introduction of VGo Telepresence Robots enhances the accessibility of healthcare services, further benefiting patients. Vecna provides an extensive array of patient intake tools, including Kiosks, Tablet Check-In, HealthPass Mobile Check-In, and the VGo Virtual Patient Intake Robot. By reducing contact throughout the entire care journey—from scheduling appointments to treatment—the Vecna Patient Intake Platform effectively lowers the risk of exposure for both patients and healthcare workers. This innovative methodology not only prioritizes safety but also guarantees a more efficient and pleasant experience for all participants in the healthcare process. Ultimately, the combination of technology and thoughtful design in healthcare settings paves the way for a more patient-centered approach.

An intuitive real-time user interface created for use at the point of care significantly improves the prevention of Drug-Related Problems (DRPs) tailored to individual patients. DRPs rank as the fourth leading cause of mortality in the United States, resulting in around 150,000 deaths annually and comprising 6-10% of all hospital admissions. Moreover, patients who are prescribed five or more medications face over a 20% likelihood of experiencing serious DRPs, which in turn contribute to billions of dollars in avoidable healthcare expenses. Each month, nearly 4.5 million individuals in the U.S. visit emergency rooms due to complications arising from DRPs. The platform features the most extensive data integration available, offering 50% more unique information and the ability to synchronize data from multiple sources. By leveraging AI and machine learning, it delivers real-time insights customized to each patient, incorporating factors such as lab results, estimated glomerular filtration rate (eGFR), genetic profiles, dietary habits, and usage of over-the-counter drugs. With a remarkable accuracy rate of 98% for both specificity and sensitivity, it significantly reduces alert fatigue by generating only 6% of the alerts typically issued by conventional systems. Additionally, the patented visualization technology employed at the point of care facilitates the swift detection, prioritization, and resolution of issues within a rapid timeframe of just 5 to 10 seconds, ensuring that patient care is both timely and effective. This cutting-edge methodology not only reduces the risks linked to DRPs but also promotes overall healthcare efficiency, ultimately leading to improved patient outcomes and satisfaction.